These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26086515)

  • 101. Pharmacogenetics - getting closer.
    Macdonald IM
    Open Ophthalmol J; 2009 Sep; 3():46-9. PubMed ID: 19816587
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Let's banish pain in pediatrics procedures].
    González Dambrauskas S; Castro BA; Kohn Loncarica G; Prego Petit J; Rino PB
    Arch Argent Pediatr; 2015 Oct; 113(5):e310-1. PubMed ID: 26521304
    [No Abstract]   [Full Text] [Related]  

  • 103. Pharm-econogenomics: a new appraisal.
    Barrett PM; Topol EJ
    Clin Chem; 2013 Apr; 59(4):592-4. PubMed ID: 23378570
    [No Abstract]   [Full Text] [Related]  

  • 104. Precision medicine, genomics and drug discovery.
    Cardon LR; Harris T
    Hum Mol Genet; 2016 Oct; 25(R2):R166-R172. PubMed ID: 27538422
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cardiovascular pharmacogenomics: current status and future directions.
    Roden DM
    J Hum Genet; 2016 Jan; 61(1):79-85. PubMed ID: 26178435
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Pharmacogenetic studies update in type 2 diabetes mellitus.
    Singh S; Usman K; Banerjee M
    World J Diabetes; 2016 Aug; 7(15):302-15. PubMed ID: 27555891
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record.
    Nishimura AA; Tarczy-Hornoch P; Shirts BH
    Curr Genet Med Rep; 2014 Dec; 2(4):201-211. PubMed ID: 26146597
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Systems medicine, personalized health and therapy.
    Siest G; Auffray C; Taniguchi N; Ingelman-Sundberg M; Murray H; Visvikis-Siest S; Ansari M; Marc J; Jacobs P; Meyer U; Van Schaik RH; Müller MM; Wevers RA; Simmaco M; Kussmann M; Manolopoulos VG; Alizadeh BZ; Beastall G; Németh G
    Pharmacogenomics; 2015; 16(14):1527-39. PubMed ID: 26401575
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome.
    Wei YQ; Wang DG; Yang H; Cao H
    PLoS One; 2015; 10(7):e0132561. PubMed ID: 26147597
    [TBL] [Abstract][Full Text] [Related]  

  • 111. CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine.
    Klieber M; Oberacher H; Hofstaetter S; Beer B; Neururer M; Amann A; Alber H; Modak A
    J Pharmacol Exp Ther; 2015 Sep; 354(3):426-30. PubMed ID: 26159874
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation. A systematic review and meta-analysis.
    Belley-Cote EP; Hanif H; D'Aragon F; Eikelboom JW; Anderson JL; Borgman M; Jonas DE; Kimmel SE; Manolopoulos VG; Baranova E; Maitland-van der Zee AH; Pirmohamed M; Whitlock RP
    Thromb Haemost; 2015 Oct; 114(4):768-77. PubMed ID: 26158747
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients.
    Dzekova-Vidimliski P; Nikolov IG; Matevska-Geshkovska N; Mena S; Rostaing L; Dimovski A; Sikole A
    Ren Fail; 2015 Aug; 37(7):1180-4. PubMed ID: 26156685
    [TBL] [Abstract][Full Text] [Related]  

  • 114. CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
    Tomaz PR; Santos JR; Issa JS; Abe TO; Gaya PV; Krieger JE; Pereira AC; Santos PC
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1067-73. PubMed ID: 26153084
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Drifting Away from Informed Consent in the Era of Personalized Medicine.
    Parens E
    Hastings Cent Rep; 2015; 45(4):16-20. PubMed ID: 26152385
    [No Abstract]   [Full Text] [Related]  

  • 116. A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window.
    Malhotra N; Abunassar J; Wells GA; McPherson R; Fu A; Hibbert B; Labinaz M; Le May M; Dick A; Glover C; Froeschl M; Marquis JF; Tran L; Bernick J; Chong AY; So DY;
    Int J Cardiol; 2015 Oct; 197():318-25. PubMed ID: 26151596
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting.
    Droppa M; Karathanos A; Gawaz M; Geisler T
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150610
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Use of genetic data to guide therapy in arterial disease.
    Ross S; Nejat S; Paré G
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S281-9. PubMed ID: 26149037
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Warfarin pharmacogenomics: current best evidence.
    Kimmel SE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S266-71. PubMed ID: 26149035
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Genetic Variants Influencing Patient Response to Opioid Therapy.
    Tadje M
    Oncol Nurs Forum; 2015 Jul; 42(4):420-2. PubMed ID: 26148323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.